APA

Lindmark F., Zheng S. L., Wiklund F., Bälter K. A., Sun J., Chang B., Hedelin M., Clark J., Johansson J., Meyers D. A., Adami H., Isaacs W., Grönberg H. & Xu J. (20050920). Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. : British journal of cancer.

Chicago

Lindmark F, Zheng S L, Wiklund F, Bälter K A, Sun J, Chang B, Hedelin M, Clark J, Johansson J-E, Meyers D A, Adami H-O, Isaacs W, Grönberg H and Xu J. 20050920. Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. : British journal of cancer.

Harvard

Lindmark F., Zheng S. L., Wiklund F., Bälter K. A., Sun J., Chang B., Hedelin M., Clark J., Johansson J., Meyers D. A., Adami H., Isaacs W., Grönberg H. and Xu J. (20050920). Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. : British journal of cancer.

MLA

Lindmark F, Zheng S L, Wiklund F, Bälter K A, Sun J, Chang B, Hedelin M, Clark J, Johansson J-E, Meyers D A, Adami H-O, Isaacs W, Grönberg H and Xu J. Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. : British journal of cancer. 20050920.